Skip to main content
Top
Published in: Diabetologia 1/2005

01-01-2005 | Article

An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study

Authors: A. Y. T. Wu, N. C. T. Kong, F. A. de Leon, C. Y. Pan, T. Y. Tai, V. T. F. Yeung, S. J. Yoo, A. Rouillon, M. R. Weir, for the MAPS Investigators

Published in: Diabetologia | Issue 1/2005

Login to get access

Abstract

Aim/hypothesis

Microalbuminuria represents the earliest clinical evidence of diabetic nephropathy and is a marker of increased cardiovascular morbidity and mortality. Its early detection allows the implementation of individualised and aggressive intervention programmes to reduce cardiovascular risk factors. There is limited information on the prevalence of microalbuminuria among hypertensive type 2 diabetic patients in Asia.

Methods

This cross-sectional epidemiological study aimed to assess the prevalence of microalbuminuria and macroalbuminuria among consecutively screened hypertensive type 2 diabetic adult patients in 103 centres in 10 Asian countries or regions. Predictive factors for microalbuminuria and macroalbuminuria were characterised using a stepwise logistic regression model.

Results

A total of 6,801 patients were enrolled and 5,549 patients constituted the per-protocol population (patients with bacteriuria and haematuria were excluded). The prevalence of microalbuminuria was 39.8% (39.2–40.5; 95% CI) and the prevalence of macroalbuminuria was 18.8% (18.2–19.3; 95% CI). Only 11.6% of the patients had systolic and diastolic blood pressure below the 130/80 mm Hg target. In the multivariate analyses, the predictive factors for the presence of microalbuminuria were age, BMI, systolic blood pressure and ethnic origin. The highlighted predictive factors for the presence of macroalbuminuria were age, sex, ethnic origin, BMI, duration of diabetes, presence of diabetic complications, intake of diuretics, intake of calcium channel blockers, diastolic and systolic blood pressure.

Conclusions/interpretation

The high prevalence (58.6%) of micro or macroalbuminuria observed in these patients is alarming and indicates an impending pandemic of diabetic cardiovascular and renal diseases in Asia with its potential economic consequences.
Literature
1.
go back to reference Epstein M, Sowers JR (1992) Diabetes mellitus and hypertension. Hypertension 19:403–418PubMed Epstein M, Sowers JR (1992) Diabetes mellitus and hypertension. Hypertension 19:403–418PubMed
2.
go back to reference Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetic, other risk factors and 12 year cardiovascular mortality for men screened in Multiple Risk Factor Intervention Trial. Diabetes Care 16:434–444PubMed Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetic, other risk factors and 12 year cardiovascular mortality for men screened in Multiple Risk Factor Intervention Trial. Diabetes Care 16:434–444PubMed
5.
go back to reference Dinneen SF, Gerstein HC (1997) The association of microalbuminuria in non-insulin-dependent diabetes mellitus. Arch Intern Med 157:1413–1418CrossRefPubMed Dinneen SF, Gerstein HC (1997) The association of microalbuminuria in non-insulin-dependent diabetes mellitus. Arch Intern Med 157:1413–1418CrossRefPubMed
6.
go back to reference Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1996) Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 27:2033–2039PubMed Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1996) Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 27:2033–2039PubMed
7.
go back to reference Wang SL, Head J, Stevens L, Fuller JH (1996) Excess mortality and its relation to hypertension and proteinuria in diabetic patients. Diabetes Care 19:305–311PubMed Wang SL, Head J, Stevens L, Fuller JH (1996) Excess mortality and its relation to hypertension and proteinuria in diabetic patients. Diabetes Care 19:305–311PubMed
8.
go back to reference De Zeeuw D, Remuzzi G, Parving HH et al (2004) Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 65:2309–2320CrossRefPubMed De Zeeuw D, Remuzzi G, Parving HH et al (2004) Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 65:2309–2320CrossRefPubMed
9.
go back to reference American Diabetes Association (2004) Nephropathy in diabetes. Position statement. Diabetes Care 27(Suppl 1):S79–S83 American Diabetes Association (2004) Nephropathy in diabetes. Position statement. Diabetes Care 27(Suppl 1):S79–S83
10.
go back to reference Spooren PF, Lekkerkerker JF, Vermes I (1992) Micral-test: a qualitative dipstick test for micro-albuminuria. Diabetes Res Clin Pract 18:83–87CrossRefPubMed Spooren PF, Lekkerkerker JF, Vermes I (1992) Micral-test: a qualitative dipstick test for micro-albuminuria. Diabetes Res Clin Pract 18:83–87CrossRefPubMed
11.
go back to reference Mather HM, Chaturvedi N, Kehely AM (1998) Comparison of prevalence and risk factors for microalbuminuria in South Asians and Europeans with type 2 diabetes mellitus. Diabet Med 15:672–677CrossRefPubMed Mather HM, Chaturvedi N, Kehely AM (1998) Comparison of prevalence and risk factors for microalbuminuria in South Asians and Europeans with type 2 diabetes mellitus. Diabet Med 15:672–677CrossRefPubMed
12.
go back to reference Varghese A, Deepa R, Rema M, Mohan V (2001) Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetic center in South India. Post-Grad Med J 77:399–402CrossRef Varghese A, Deepa R, Rema M, Mohan V (2001) Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetic center in South India. Post-Grad Med J 77:399–402CrossRef
13.
go back to reference Tomura S, Kawada K, Saito K et al (1999) Prevalence of microalbuminuria and relationship to the risk of cardiovascular disease in the Japanese population. Am J Nephrol 19:13–20CrossRefPubMed Tomura S, Kawada K, Saito K et al (1999) Prevalence of microalbuminuria and relationship to the risk of cardiovascular disease in the Japanese population. Am J Nephrol 19:13–20CrossRefPubMed
14.
go back to reference Lee WRW, Lim HS, Thai AC et al (2001) A window in the current status of diabetes mellitus in Singapore—The Diabcare-Singapore 1998 study. Singap Med J 42:501–507 Lee WRW, Lim HS, Thai AC et al (2001) A window in the current status of diabetes mellitus in Singapore—The Diabcare-Singapore 1998 study. Singap Med J 42:501–507
15.
go back to reference Guidelines Sub-Committee (1999) World Health Organization—International Society of Hypertension guidelines for the management of hypertension. J Hypertens 17:151–183 Guidelines Sub-Committee (1999) World Health Organization—International Society of Hypertension guidelines for the management of hypertension. J Hypertens 17:151–183
16.
go back to reference Parving HH, Osterby R, Ritz E (2000) Diabetic nephropathy. In: BM Brenner (ed) The kidney. WB Saunders, Philadelphia, pp 1731–1773 Parving HH, Osterby R, Ritz E (2000) Diabetic nephropathy. In: BM Brenner (ed) The kidney. WB Saunders, Philadelphia, pp 1731–1773
17.
go back to reference Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC (1990) Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 33:438–443CrossRefPubMed Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC (1990) Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 33:438–443CrossRefPubMed
18.
go back to reference Kuusisto J, Mykkanen L, Pyorala K, Laakso M (1995) Hyperinsulinemic microalbuminuria: a new risk indicator for coronary artery disease. Circulation 90:831–837 Kuusisto J, Mykkanen L, Pyorala K, Laakso M (1995) Hyperinsulinemic microalbuminuria: a new risk indicator for coronary artery disease. Circulation 90:831–837
19.
go back to reference Ramachandran A, Snehalatha C, Vijay V (2004) Low risk threshold for acquired diabetogenic factors in Asian Indians. Diabetes Res Clin Pract 65:189–195CrossRefPubMed Ramachandran A, Snehalatha C, Vijay V (2004) Low risk threshold for acquired diabetogenic factors in Asian Indians. Diabetes Res Clin Pract 65:189–195CrossRefPubMed
20.
go back to reference Oh JY, Hong YS, Sung YA, Barrett-Connor E (2004) Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care 27:2027–2032PubMed Oh JY, Hong YS, Sung YA, Barrett-Connor E (2004) Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care 27:2027–2032PubMed
21.
go back to reference Misra A, Vikram NK (2004) Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition 20:482–491CrossRefPubMed Misra A, Vikram NK (2004) Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition 20:482–491CrossRefPubMed
22.
go back to reference Tarnow L, Rossing P, Gall MA, Nielsen FS, Parving HH (1994) Prevalence of arterial hypertension in diabetic patients before and after JNC-V. Diabetes Care 17:1247–1251PubMed Tarnow L, Rossing P, Gall MA, Nielsen FS, Parving HH (1994) Prevalence of arterial hypertension in diabetic patients before and after JNC-V. Diabetes Care 17:1247–1251PubMed
23.
go back to reference Lewis EJ, Hunsicker LG, Clarke WR et al (2001) Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851–860CrossRefPubMed Lewis EJ, Hunsicker LG, Clarke WR et al (2001) Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851–860CrossRefPubMed
24.
go back to reference Bakris GL, Weir MR, Secic M, Campbell B, Weis-McNulty A (2004) Differential effects of calcium antagonist subclasses on markers of nephropathy progression. Kidney Int 65:1991–2002CrossRefPubMed Bakris GL, Weir MR, Secic M, Campbell B, Weis-McNulty A (2004) Differential effects of calcium antagonist subclasses on markers of nephropathy progression. Kidney Int 65:1991–2002CrossRefPubMed
25.
go back to reference (1997) Sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157:2413–2446 (1997) Sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157:2413–2446
26.
go back to reference Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H (2001) Mortality and causes of death in the WHO multinational study of vascular disease in diabetics. Diabetologia 44(Suppl 2):S14–S21PubMed Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H (2001) Mortality and causes of death in the WHO multinational study of vascular disease in diabetics. Diabetologia 44(Suppl 2):S14–S21PubMed
27.
go back to reference Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P (2001) The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345:870–878CrossRefPubMed Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P (2001) The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345:870–878CrossRefPubMed
28.
go back to reference Brenner BM, Cooper ME, De Zeeuw D et al (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861–869CrossRefPubMed Brenner BM, Cooper ME, De Zeeuw D et al (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861–869CrossRefPubMed
29.
go back to reference Bakris GL, Williams M, Dworkin L et al (2000) Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 36:646–661PubMed Bakris GL, Williams M, Dworkin L et al (2000) Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 36:646–661PubMed
30.
go back to reference The JNC-7 Report (2003) The 7th report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 289:2560–2572CrossRefPubMed The JNC-7 Report (2003) The 7th report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 289:2560–2572CrossRefPubMed
31.
go back to reference UKPDS 33 (1998) Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in NIDDM. Lancet 352:837–852 UKPDS 33 (1998) Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in NIDDM. Lancet 352:837–852
Metadata
Title
An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study
Authors
A. Y. T. Wu
N. C. T. Kong
F. A. de Leon
C. Y. Pan
T. Y. Tai
V. T. F. Yeung
S. J. Yoo
A. Rouillon
M. R. Weir
for the MAPS Investigators
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 1/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1599-9

Other articles of this Issue 1/2005

Diabetologia 1/2005 Go to the issue

list of referees

List of referees